JP2023528397A5 - - Google Patents
Info
- Publication number
- JP2023528397A5 JP2023528397A5 JP2022573665A JP2022573665A JP2023528397A5 JP 2023528397 A5 JP2023528397 A5 JP 2023528397A5 JP 2022573665 A JP2022573665 A JP 2022573665A JP 2022573665 A JP2022573665 A JP 2022573665A JP 2023528397 A5 JP2023528397 A5 JP 2023528397A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- disease
- pharmaceutically acceptable
- acceptable salt
- chronic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063031023P | 2020-05-28 | 2020-05-28 | |
| US63/031,023 | 2020-05-28 | ||
| PCT/CA2021/050725 WO2021237364A1 (en) | 2020-05-28 | 2021-05-28 | Gut microbiota bioactivated pde4 inhibitor precursors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023528397A JP2023528397A (ja) | 2023-07-04 |
| JP2023528397A5 true JP2023528397A5 (https=) | 2024-06-04 |
| JP7762168B2 JP7762168B2 (ja) | 2025-10-29 |
Family
ID=78745382
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022573665A Active JP7762168B2 (ja) | 2020-05-28 | 2021-05-28 | 腸内微生物叢の生物活性化ｐｄｅ４阻害剤前駆体 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230250123A1 (https=) |
| EP (1) | EP4157853B1 (https=) |
| JP (1) | JP7762168B2 (https=) |
| KR (1) | KR20230029682A (https=) |
| CN (1) | CN116056713B (https=) |
| AU (1) | AU2021280418A1 (https=) |
| ES (1) | ES2989065T3 (https=) |
| MX (1) | MX2022014416A (https=) |
| WO (1) | WO2021237364A1 (https=) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6200993B1 (en) * | 1999-05-05 | 2001-03-13 | Merck Frosst Canada & Co. | Heterosubstituted pyridine derivatives as PDE4 inhibitors |
| MY123585A (en) * | 2000-03-23 | 2006-05-31 | Merck Canada Inc | Tri-aryl-substituted-ethane pde4 inhibitors. |
| AU2003281219A1 (en) * | 2002-07-02 | 2004-01-23 | Bernard Cote | Di-aryl-substituted-ethane pyridone pde4 inhibitors |
| WO2007142929A2 (en) * | 2006-05-31 | 2007-12-13 | The University Of North Carolina At Chapel Hill | Novel pde4 inhibitors |
-
2021
- 2021-05-28 EP EP21813912.9A patent/EP4157853B1/en active Active
- 2021-05-28 CN CN202180058681.5A patent/CN116056713B/zh active Active
- 2021-05-28 AU AU2021280418A patent/AU2021280418A1/en active Pending
- 2021-05-28 MX MX2022014416A patent/MX2022014416A/es unknown
- 2021-05-28 JP JP2022573665A patent/JP7762168B2/ja active Active
- 2021-05-28 KR KR1020227045933A patent/KR20230029682A/ko active Pending
- 2021-05-28 ES ES21813912T patent/ES2989065T3/es active Active
- 2021-05-28 US US17/927,827 patent/US20230250123A1/en active Pending
- 2021-05-28 WO PCT/CA2021/050725 patent/WO2021237364A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101644170B1 (ko) | 씨알티에이치2 길항제 활성을 갖는 화합물 | |
| TWI344961B (en) | Novel indazole derivative | |
| KR100605140B1 (ko) | 심장병 및 다른 질병을 치료하기 위한 헤테로 고리 화합물및 그 치료 방법 | |
| JP2763962B2 (ja) | インドール誘導体トロンボキサンａ２アンタゴニスト | |
| EP1856045B1 (en) | 1-acetic acid-indole derivatives with pgd2 antagonist activity | |
| TWI423962B (zh) | 有效作為黃嘌呤氧化酶抑制劑之新穎化合物、其製備方法及含該化合物之醫藥組成物 | |
| JP4627944B2 (ja) | 置換ピラゾール化合物 | |
| TWI435875B (zh) | 含氮芳香族雜環化合物 | |
| JP5008778B2 (ja) | 新規５−フルオロウラシル誘導体 | |
| KR20090042808A (ko) | 씨알티에이치2 길항제 활성을 갖는 화합물 | |
| TW200806645A (en) | Heteropentacycles active as kinase inhibitors | |
| JP2000016984A (ja) | デルタオピオイドアゴニストとしての化合物 | |
| TW200804345A (en) | Substituted benzimidazoles and methods of preparation | |
| WO2005044260A1 (en) | Use of crth2 antagonist compounds in therapy | |
| JP2016128414A (ja) | ピリミジン誘導体の製造プロセス | |
| WO2001060803A1 (en) | Fused imidazolium derivatives | |
| WO2005035501A1 (ja) | 新規オレフィン誘導体 | |
| CN110191709A (zh) | 可用作吲哚胺2,3-双加氧酶和/或色氨酸双加氧酶抑制剂的化合物 | |
| TW201623239A (zh) | 新穎２－胺基－吡啶及２－胺基－嘧啶衍生物及其醫藥用途 | |
| CN112574201B (zh) | 芳基胺类化合物、包含其的药物组合物及其制备方法和用途 | |
| JP2023528397A5 (https=) | ||
| TW202329944A (zh) | Ampk活化劑 | |
| TW201536769A (zh) | 尿素化合物及其作爲酵素抑制劑之用途（一） | |
| CN101674828A (zh) | 用于治疗甲状腺癌的Raf抑制剂 | |
| JP2006527203A (ja) | グルタミン酸受容体アンタゴニストであるヘテロアリール置換イミダゾール誘導体 |